June 14, 2017

Marlene Freeman, M.D.

Marlene Freeman, M.D.

Director of Clinical Services

University of Arizona



Marlene is the Director of Clinical Services in the Perinatal and Reproductive Psychiatry Clinical Research Program at Massachusetts General Hospital and an Associate Professor of Psychiatry at Harvard Medical School.

Dr. Freeman’s clinical and research experience has been focused on antenatal and postpartum depression, as well as integrative treatment strategies for mood disorders. She completed undergraduate work at the University of Wisconsin and medical school at Northwestern University Medical School. She completed her residency at the Harvard Longwood Psychiatry Residency Program and served as a co-investigator in the first clinical trial of adjunctive omega-3 fatty acids for the treatment of bipolar disorder. After residency, she completed a research fellowship in the Biological Psychiatry Program at the University of Cincinnati College of Medicine, focused on bipolar disorder treatment research. Dr. Freeman established the

University of Arizona’s Women’s Mental Health Program in 2000 and directed the program for seven years. She developed a research program in perinatal depression with grant support from NARSAD, the National Institute of Mental Health, the U.S. FDA, the Arizona Disease Control Research Commission, and the Institute for Mental Health Research. These grants supported research in perinatal depression. From 2007-8, she served as the Director of the Women’s Mental Health Center at UT Southwestern Medical Center. She serves as Vice Editor-in-Chief for The Journal of Clinical Psychiatry since 2007, after serving as Deputy Editor since 2003. She chaired a subcommittee on Omega-3 Fatty Acids in Psychiatry, on behalf of the American Psychiatric Association (APA). She currently chairs the APA’s Task Force on Complementary and Alternative Medicine. She served on the APA’s Major Depressive Disorder Treatment Guideline Revision.

Title of Grant Funded:
Neonatal Antidepressant Syndrome: Drug Exposure of Maternal Depression